For Investors

Press Releases

Real-Time Stocks

SEC Filings

Corporate Profile

Code of Ethics

Nominating Committee

 

Press Releases


MILESTONE SCIENTIFIC TO EXHIBIT AT The CDA ART and Science of Dentistry Spring Session

LIVINGSTON, N.J. – (PR NEWSWIRE) – April 30, 2009 – Milestone Scientific Inc. (OTCBB:MLSS), the recognized leader in advanced injection technologies, today announced that it will be showcasing its award-winning STA Single Tooth Anesthesia System™ (STA System) at the upcoming CDA Presents the Art and Science of Dentistry (formerly known as Scientific Sessions).  

WHEN:           
Thursday, May 14, 2009 - Sunday, May 17, 2009

WHERE:           
Booth #1641
Anaheim Convention Center
800 W. Katella Avenue
Anaheim, California

WHO:             
Bob Presutti, Vice President of Sales & Marketing
Scott Mahnken, Director of Marketing

WHAT:           
Demonstrations of the STA System

Learn first-hand how Milestone is redefining the standard of care for the delivery of local anesthesia by allowing dentists to more comfortably administer all dental injections.

Discover how the STA System is helping dentists to increase their earnings through improvements in their dental practice efficiency, which is important in this economic environment.

The state-of-the-art STA System is a computer-controlled, pressure-sensitive injection system, which provides dentists with audible and visual signals as to in-tissue pressure and needle location.  Milestone’s latest achievement in Computer-Controlled Local Anesthetic Delivery (C-CLAD) makes the injection process more comfortable for both dentists and patients and allows for the painless delivery of local anesthetic.  Marketed worldwide by Milestone’s growing global distributor network to dental practitioners for the painless administration of all dental injections, the STA System is uniquely capable of predictably and more comfortably administering “Single Tooth Anesthesia” into the Periodontal Intraligamentary (PDL) space, something never before possible using conventional techniques.

NOTE TO PRESS: To arrange one-on-one interviews with management or to schedule a personal demonstration of the STA System at the event,  please contact Tiffany Korkis or Kathy Addison, Directors, Elite Media Group, at 407-585-1080 or via email at MLSS@efcg.net.

About CDA
The California Dental Association is the largest statewide dental association in the country, and  the nearly 24,000 members represent almost 70 percent of dentists practicing in the state. The CDA organization is comprised of CDA, the CDA Foundation, The Dentists Insurance Company and TDIC Insurance Solutions.  Founded in 1870, the CDA is part of a membership structure that includes 32 local dental societies and the American Dental Association.  They represent the single largest membership in the American Dental Association.  One out of seven ADA members is also a member of CDA.

About Milestone Scientific Inc.
Headquartered in Livingston, New Jersey, Milestone Scientific is engaged in pioneering proprietary, highly innovative technological solutions for the medical and dental markets.  Central to the Company’s IP platform and product development strategy is its patented CompuFlo® technology for the improved and painless delivery of local anesthetic.  Specifically, CompuFlo is a computer-controlled, pressure sensitive infusion, perfusion, suffusion and aspiration technology, which provides real-time readouts of pressures, fluid densities and flow rates, enabling the advanced delivery and removal of a wide array of fluids.  The STA Single Tooth Anesthesia System™, a computer-controlled local anesthesia delivery system, uses this technology to provide dentists with audible and visual signals as to in-tissue pressure.  Milestone’s existing painless injection systems are currently sold in 25 countries.  For more information on these and other innovative Milestone products, please visit the Company’s web site found at www.milesci.com and www.STAis4U.com.

Safe Harbor Statement
This press release contains forward-looking statements regarding the timing and financial impact of the Milestone's ability to implement its business plan, expected revenues and future success.  These statements involve a number of risks and uncertainties and are based on assumptions involving judgments with respect to future economic, competitive and market conditions and future business decisions, all of which are difficult or impossible to predict accurately and many of which are beyond Milestone's control. Some of the important factors that could cause actual results to differ materially from those indicated by the forward-looking statements are general economic conditions, failure to achieve expected revenue growth, changes in our operating expenses, adverse patent rulings, FDA or legal developments, competitive pressures, changes in customer and market requirements and standards, and the risk factors detailed from time to time in Milestone's periodic filings with the Securities and Exchange Commission, including without limitation, Milestone's Annual Report  for the year ended December 31, 2008. The forward looking-statements in this press release are based upon management's reasonable belief as of the date hereof.  Milestone undertakes no obligation to revise or update publicly any forward-looking statements for any reason.

FOR MORE INFORMATION, PLEASE CONTACT:
Elite Financial Communications Group
Dodi Handy, President and CEO
For Media Inquiries: Tiffany Korkis or Kathy Addison, Directors, Elite Media Group
407-585-1080 or via email at mlss@efcg.net


© Copyright 2007 Milestone Scientific. All Rights Reserved. | Terms of Use | Privacy Policy | Usage | Contact | Site Map | U.S. Map | Home